Senior Systematic Reviewer
Zulian Liu is a senior systematic reviewer in the EBCTCG. Before joining the EBCTCG, she worked in various research capacities, undertaking systematic reviews, rapid evidence reviews and health technology assessments for UK regional and national organisations including the National Institute for Health and Care Excellence (NICE) and the National Institute for Health Research (NIHR) on a wide range of health topics and technologies. Prior to her UK academic career, Zulian worked as a paediatrician in China.
Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis.
Richards SH. et al, (2018), European journal of preventive cardiology, 25, 247 - 259
Adverse effects of extracorporeal carbon dioxide removal (ECCO2R) for acute respiratory failure: a systematic review protocol
Liu Z. et al, (2016), Systematic Reviews, 5
Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation.
Rogers G. et al, (2012), Health Technology Assessment, 16
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
Hoyle M. et al, (2011), Value in Health, 14, 1057 - 1067
Reply: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival
Thompson Coon JS. et al, (2010), British Journal of Cancer, 102, 234 - 235